Volume 5 Supplement 2

1st Workshop of the International Society for Behçet's Disease (ISBD) on Pathophysiology and Treatment of Behçet's Disease

Meeting abstracts

Edited by S Assaad-Khalil, H Direskeneli, M Schirmer

This workshop was supported in part by Merck Austria and the Scientific Society of Hematology, Oncology and Immunology, Innsbruck Austria

1st Workshop of the International Society for Behçet's Disease (ISBD) on Pathophysiology and Treatment of Behçet's Disease. Go to conference site.

Kühtai, Austria2-5 April 2003

Introduction

Authors: CG Barnes

Citation: Arthritis Res Ther 2003 5(Suppl 2):1

Content type: Meeting abstract Published on: 9 September 2003
- View Full Text
- View PDF
Perspectives of the Working Group on Drug Trials including Collaborative Trials of the ISBD and rationale for new clinical trials

Authors: S Assaad-Khalil

Citation: Arthritis Res Ther 2003 5(Suppl 2):2

Content type: Meeting abstract Published on: 9 September 2003
- View Full Text
- View PDF
Cytotoxic drugs in ocular lesions of Behçet's disease

Authors: F Davatchi, F Shahram, H Chams, A Nadji, AR Jamshidi, C Chams, M Akbarian, F Gharibdoost, M Sedigh and B Sadeghi

Citation: Arthritis Res Ther 2003 5(Suppl 2):3

Content type: Meeting abstract Published on: 9 September 2003
- View Full Text
- View PDF
The use of interferon-alfa in Behçet's disease: review of the literature

Authors: I Kötter, I Günaydin, M Zierhut and N Stübiger

Citation: Arthritis Res Ther 2003 5(Suppl 2):4

Content type: Meeting abstract Published on: 9 September 2003
- View Full Text
- View PDF
Efficacy of recombinant human interferon-alfa2a on ocular and extra-ocular manifestations of Behçet's disease and influence on cells of the immune system: results of an open four center trial

Authors: I Kötter, M Treusch, R Vonthein, M Zierhut, A Eckstein, T Ness, I Günaydin, B Grimbacher, S Blaschke, HH Peter and N Stübiger

Citation: Arthritis Res Ther 2003 5(Suppl 2):5

Content type: Meeting abstract Published on: 9 September 2003
- View Full Text
- View PDF
TNF and anti-TNF agents in Behçet's disease

Authors: KT Calamia

Citation: Arthritis Res Ther 2003 5(Suppl 2):6

Content type: Meeting abstract Published on: 9 September 2003
- View Full Text
- View PDF
A review on disease activity scores in Behçet's disease (BD)

Authors: M Baltaci

Citation: Arthritis Res Ther 2003 5(Suppl 2):7

Content type: Meeting abstract Published on: 9 September 2003
- View Full Text
- View PDF
Behçet's disease: from innate to adaptive immunity

Authors: H Direskeneli

Citation: Arthritis Res Ther 2003 5(Suppl 2):8

Content type: Meeting abstract Published on: 9 September 2003
- View Full Text
- View PDF
Migration of dendritic cells into the lymphatics: the Langerhans cell example

Authors: N Romani, P Stoitzner, S Ebner, H Stössel, S Holzmann, G Ratzinger and P Fritsch

Citation: Arthritis Res Ther 2003 5(Suppl 2):9

Content type: Meeting abstract Published on: 9 September 2003
- View Full Text
- View PDF
Viral infection of retinal pigment epithelium: a possible role for initiation of Behçet's disease

Authors: EU Irschick, HP Huemer, C Larcher, R Sgonc and W Göttinger

Citation: Arthritis Res Ther 2003 5(Suppl 2):10

Content type: Meeting abstract Published on: 9 September 2003
- View Full Text
- View PDF
Regulation of inflammatory CD28^- T-helper cells by HLA class I molecules: a new cellular model for Behçet's disease?

Authors: C Duftner, C Goldberger, E Märker-Hermann and M Schirmer

Citation: Arthritis Res Ther 2003 5(Suppl 2):11

Content type: Meeting abstract Published on: 9 September 2003
- View Full Text
- View PDF
Immunosuppressive effects of gemcitabine in the HSV-induced Behçet's disease like mouse model

Authors: S Sohn, M Lutz, HJ Kwon, G Konwalinka, S Lee and M Schirmer

Citation: Arthritis Res Ther 2003 5(Suppl 2):12

Content type: Meeting abstract Published on: 9 September 2003
- View Full Text
- View PDF
Streptococcal antigen in the pathogenesis of Behçet's disease

Authors: F Kaneko, H Yanagihori, M Tojo, E Isogai, SN Lin and K Oguma

Citation: Arthritis Res Ther 2003 5(Suppl 2):13

Content type: Meeting abstract Published on: 9 September 2003
- View Full Text
- View PDF

1st Workshop of the International Society for Behçet's Disease (ISBD) on Pathophysiology and Treatment of Behçet's Disease

Meeting abstracts

Introduction

Perspectives of the Working Group on Drug Trials including Collaborative Trials of the ISBD and rationale for new clinical trials

Cytotoxic drugs in ocular lesions of Behçet's disease

The use of interferon-alfa in Behçet's disease: review of the literature

Efficacy of recombinant human interferon-alfa2a on ocular and extra-ocular manifestations of Behçet's disease and influence on cells of the immune system: results of an open four center trial

TNF and anti-TNF agents in Behçet's disease

A review on disease activity scores in Behçet's disease (BD)

Behçet's disease: from innate to adaptive immunity

Migration of dendritic cells into the lymphatics: the Langerhans cell example

Viral infection of retinal pigment epithelium: a possible role for initiation of Behçet's disease

Regulation of inflammatory CD28^- T-helper cells by HLA class I molecules: a new cellular model for Behçet's disease?

Immunosuppressive effects of gemcitabine in the HSV-induced Behçet's disease like mouse model

Streptococcal antigen in the pathogenesis of Behçet's disease

Follow

Annual Journal Metrics

Arthritis Research & Therapy

Contact us